Concentrations	9 Months Ended
Sep. 30, 2019
Risks and Uncertainties [Abstract]
CONCENTRATIONS	NOTE 14 – CONCENTRATIONS Customers Five customers accounted for approximately 80% (34%, 16%, 14%, 8% and 8%) of the Company's revenues for the three months ended September 30, 2019. Five customers accounted for approximately 43% (11%, 10%, 8%, 7% and 7%) of the Company's revenues for the nine months ended September 30, 2019. The total outstanding accounts receivable balance of Customer A, B, C, D, and E are $260,079, $168,154, $70,064, $472,233 and $29,427 respectively as of September 30, 2019. Suppliers Three suppliers accounted for approximately 73% (46%,16%, 11%) of the Company's inventories purchases for the three months ended September 30, 2019. Two suppliers accounted for approximately 40% (20% and 20%) of the Company's inventories purchases for the nine months ended September 30, 2019. The total outstanding accounts payable balance of Supplier A, B and C are $278,918, $69,604 and $310,659 respectively as of September 30, 2019.

Concentrations

9 Months Ended

Sep. 30, 2019

NOTE 14 – CONCENTRATIONS

Customers

Five customers accounted for approximately 80% (34%, 16%, 14%, 8% and 8%) of the Company's revenues for the three months ended September 30, 2019.

Five customers accounted for approximately 43% (11%, 10%, 8%, 7% and 7%) of the Company's revenues for the nine months ended September 30, 2019.

The total outstanding accounts receivable balance of Customer A, B, C, D, and E are $260,079, $168,154, $70,064, $472,233 and $29,427 respectively as of September 30, 2019.

Suppliers

Three suppliers accounted for approximately 73% (46%,16%, 11%) of the Company's inventories purchases for the three months ended September 30, 2019.

Two suppliers accounted for approximately 40% (20% and 20%) of the Company's inventories purchases for the nine months ended September 30, 2019.

The total outstanding accounts payable balance of Supplier A, B and C are $278,918, $69,604 and $310,659 respectively as of September 30, 2019.